Evidence that the CCENTRAL ACTION OF (+)-amphetamine is mediated via catecholamines.
D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects*; D001921:Brain / Q000502:physiology; D002395:Catecholamines / Q000502:physiology*; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects*; D003213:Conditioning, Psychological / Q000187:drug effects*; D003913:Dextroamphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology*; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004924:Escape Reaction / Q000187:drug effects; D005260:Female; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology*; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D009411:Nerve Endings / Q000502:physiology; D011600:Psychopharmacology; D012110:Reserpine / Q000037:antagonists & inhibitors*
D002395:Catecholamines; D008781:Methyltyrosines; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D006899:Mixed Function Oxygenases; D003913:Dextroamphetamine